DNMT3A and atherosclerosis: In addition, CHIP has been shown to be associated with cardiovascular disease including atherosclerosis, thus additional studies are needed to assess DNMT3A R882 mutations’ risk for cardiovascular diseases and atherosclerosis, and whether reduction of modifiable cardiovascular risk factors is needed in this group.